ENDRA Life Sciences Inc. - FORM 10-K - EX-23.2 - CONSENT OF RBSM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (WITH RESPECT - March 25, 2021

Attached files

file filename
EX-32.1 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - ENDRA Life Sciences Inc.ndra_ex321.htm
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - ENDRA Life Sciences Inc.ndra_ex312.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - ENDRA Life Sciences Inc.ndra_ex311.htm
EX-23.1 - CONSENT OF RBSM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (WITH RESPECT - ENDRA Life Sciences Inc.ndra_ex231.htm
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - ENDRA Life Sciences Inc.ndra_ex211.htm
EX-10.18 - SECOND AMENDMENT TO LEASE, DATED MARCH 15, 2021, BY AND BETWEEN THE COMPANY AND - ENDRA Life Sciences Inc.ndra_ex1018.htm
EX-4.12 - DESCRIPTION OF SECURITIES - ENDRA Life Sciences Inc.ndra_ex412.htm
10-K - FORM 10-K - ENDRA Life Sciences Inc.ndra_10k.htm
 
Exhibit 23.2
 
 
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT
 
We consent to the incorporation by reference in the Registration Statements of ENDRA Life Sciences Inc. on Form S-8 (File Nos. 333-233178 and 333-218894) of our report dated March 25, 2021, with respect to our audits of the consolidated financial statements of ENDRA Life Sciences Inc. & Subsidiaries as of December 31, 2020 and 2019, which is included in this Annual Report on Form 10-K of ENDRA Life Sciences Inc.
 
 
/s/ RBSM LLP
 
RBSM LLP
New York, NY
March 25, 2021
 
 
 

ENDRA Life Sciences Inc. Reports